BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15128733)

  • 1. Repression of endogenous Smad7 by Ski.
    Denissova NG; Liu F
    J Biol Chem; 2004 Jul; 279(27):28143-8. PubMed ID: 15128733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ski co-repressor complexes maintain the basal repressed state of the TGF-beta target gene, SMAD7, via HDAC3 and PRMT5.
    Tabata T; Kokura K; Ten Dijke P; Ishii S
    Genes Cells; 2009 Jan; 14(1):17-28. PubMed ID: 19032343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SnoN co-repressor binds and represses smad7 gene promoter.
    Briones-Orta MA; Sosa-Garrocho M; Moreno-Alvarez P; Fonseca-Sánchez MA; Macías-Silva M
    Biochem Biophys Res Commun; 2006 Mar; 341(3):889-94. PubMed ID: 16442497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Smad7 promoter by direct association with Smad3 and Smad4.
    Nagarajan RP; Zhang J; Li W; Chen Y
    J Biol Chem; 1999 Nov; 274(47):33412-8. PubMed ID: 10559222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta -inducible independent binding of SMAD to the Smad7 promoter.
    Denissova NG; Pouponnot C; Long J; He D; Liu F
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6397-402. PubMed ID: 10823886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta.
    von Gersdorff G; Susztak K; Rezvani F; Bitzer M; Liang D; Böttinger EP
    J Biol Chem; 2000 Apr; 275(15):11320-6. PubMed ID: 10753944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.
    Xu W; Angelis K; Danielpour D; Haddad MM; Bischof O; Campisi J; Stavnezer E; Medrano EE
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5924-9. PubMed ID: 10811875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. THE TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation.
    Stopa M; Anhuf D; Terstegen L; Gatsios P; Gressner AM; Dooley S
    J Biol Chem; 2000 Sep; 275(38):29308-17. PubMed ID: 10887185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultraviolet irradiation induces Smad7 via induction of transcription factor AP-1 in human skin fibroblasts.
    Quan T; He T; Voorhees JJ; Fisher GJ
    J Biol Chem; 2005 Mar; 280(9):8079-85. PubMed ID: 15579469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements.
    Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K
    Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct interaction of Ski with either Smad3 or Smad4 is necessary and sufficient for Ski-mediated repression of transforming growth factor-beta signaling.
    Ueki N; Hayman MJ
    J Biol Chem; 2003 Aug; 278(35):32489-92. PubMed ID: 12857746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB.
    Nagarajan RP; Chen F; Li W; Vig E; Harrington MA; Nakshatri H; Chen Y
    Biochem J; 2000 Jun; 348 Pt 3(Pt 3):591-6. PubMed ID: 10839991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of action of acetaldehyde in the up-regulation of the human α2(I) collagen gene in hepatic stellate cells: key roles of Ski, SMAD3, SMAD4, and SMAD7.
    Reyes-Gordillo K; Shah R; Arellanes-Robledo J; Hernández-Nazara Z; Rincón-Sánchez AR; Inagaki Y; Rojkind M; Lakshman MR
    Am J Pathol; 2014 May; 184(5):1458-67. PubMed ID: 24641900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DACH1 inhibits transforming growth factor-beta signaling through binding Smad4.
    Wu K; Yang Y; Wang C; Davoli MA; D'Amico M; Li A; Cveklova K; Kozmik Z; Lisanti MP; Russell RG; Cvekl A; Pestell RG
    J Biol Chem; 2003 Dec; 278(51):51673-84. PubMed ID: 14525983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of MAP kinase cascades in Smad7 transcriptional regulation.
    Uchida K; Suzuki H; Ohashi T; Nitta K; Yumura W; Nihei H
    Biochem Biophys Res Commun; 2001 Nov; 289(2):376-81. PubMed ID: 11716483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient TGF-beta induction of the Smad7 gene requires cooperation between AP-1, Sp1, and Smad proteins on the mouse Smad7 promoter.
    Brodin G; Ahgren A; ten Dijke P; Heldin CH; Heuchel R
    J Biol Chem; 2000 Sep; 275(37):29023-30. PubMed ID: 10843994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration.
    Macias-Silva M; Li W; Leu JI; Crissey MA; Taub R
    J Biol Chem; 2002 Aug; 277(32):28483-90. PubMed ID: 12023281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells.
    Lee EO; Kang JL; Chong YH
    J Biol Chem; 2005 Mar; 280(9):7845-53. PubMed ID: 15632190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
    Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
    Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Jun associates with the oncoprotein Ski and suppresses Smad2 transcriptional activity.
    Pessah M; Marais J; Prunier C; Ferrand N; Lallemand F; Mauviel A; Atfi A
    J Biol Chem; 2002 Aug; 277(32):29094-100. PubMed ID: 12034730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.